| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | trifluoperazine | CTRPv2 | pan-cancer | AAC | 0.0064 | 0.9 |
| mRNA | navitoclax:piperlongumine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | XL765 | CTRPv2 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.0057 | 0.9 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | tosedostat | CTRPv2 | pan-cancer | AAC | -0.0055 | 0.9 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |